Companies Dominating the Lab Evolved Enzymes Landscape
- AB Enzymes GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- 121 Bio, LLC
- Aeglea BioTherapeutics, Inc.
- AM-Pharma B.V.
- Alphazyme LLC
- APEIRON Biologics AG
- Aronora, Inc.
- Arzeda
- Aralez Bio
- BIO-CAT
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Lab Evolved Enzymes Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2025-2037.
The market growth is driven by growing emphasis towards renewable energy, and increasing demand for natural substitute for synthetic chemicals.
North America industry is likely to hold largest revenue share by 2037, due to development of novel and superior performing products in the region.
The major players in the market are AB Enzymes GmbH, 121 Bio, LLC, Aeglea BioTherapeutics, Inc., AM-Pharma B.V., Alphazyme LLC, and others.
